bpc-157 vs stem cells for longevity and tissue repair & TB-500: Prioritize Nutrition Connective Stem-cell therapy and platelet-rich plasma

2009;296:E11109

While management of the underlying cause of the peripheral neuropathy (if applicable) is essential, treatment of the peripheral neuropathy itself includes combination of oral medication, prescription creams, physical therapy, and regenerative medicine

In September 2023, the FDA classified BPC-157 as a Category 2 compound under the 503A bulking list, restricting its use by American compounding pharmacies

Multi-Pathway Cytoskeletal Research BPC-157 modulates cytoskeletal signalling through the FAK-paxillin pathway affecting cell adhesion complex dynamics and mechanosensing

Most patients use Lipo-B weekly